Zantac Trials Expected in 2023

There are currently more than 70,000 product liability lawsuits filed by former users of the recalled heartburn drug, Zantac (ranitidine). A court order issued in the Southern District of Florida anticipates that bellwether trials will begin in 2023 for cases connected to cancer diagnoses after using Zantac. Selection of the bellwether trials is likely to be completed by Summer of 2022.

Zantac has been linked to several different types of cancer after long-term, high-dose exposure from both prescription grade and over-the-counter products. Numerous lawsuits from around the country have been filed by injured plaintiffs alleging that manufacturers of Zantac concealed the cancer link from millions of people who took the drug. 

Did You take Zantac and Receive a Cancer Diagnosis?

If you believe your cancer diagnosis was a result of taking Zantac (ranitidine), you may be legally entitled to compensation.